首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >P1.01-61 Clinical Characterization of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers
【24h】

P1.01-61 Clinical Characterization of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers

机译:ERBB2 EXON 20临床表征ERBB2 EXON 20在中国肺癌中的成果的插入和异质性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

著录项

  • 来源
  • 作者单位

    Department of Oncology General Hospital of Chinese PLA;

    Department of Oncology General Hospital of Chinese PLA;

    Department of Thoracic Medical Oncology Hunan Cancer Hospital/the Affiliated Cancer Hospital of;

    Department of Oncology Hunan Cancer Hospital;

    Department of Radiotherapy Provincial Hospital Affiliated To Shandong University;

    State Key Laboratory of Respiratory Disease guangzhou Institute of Respiratory Disease The First;

    Department of Respiratory Medicine Xiangya Hospital Central South University;

    Department of Thoracic Surgery Peking University Shenzhen Hospital;

    Department of Thoracic Surgery Ningbo No. 2 Hospital;

    Department of Respiratory Zhongshan Hospital Affiliated with Fudan University;

    Department of Oncology General Hospital of Chinese PLA;

    Burning Rock Biotech;

    Burning Rock Biotech;

    Burning Rock Biotech;

    Burning Rock Biotech;

    Burning Rock Biotech;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号